Your browser doesn't support javascript.
loading
A Case Report of Myxedema Coma in the Setting of Normal Thyroid Stimulating Hormone.
Bally, Klynt; Trusty, Rhonda-Kaye; Naher, Kamrun.
Affiliation
  • Bally K; Internal Medicine, State University of New York Downstate Medical Center, New York City, USA.
  • Trusty RK; Internal Medicine and Endocrinology, State University of New York Downstate Medical Center, New York City, USA.
  • Naher K; Endocrinology, State University of New York Downstate Medical Center, New York City, USA.
Cureus ; 16(6): e62695, 2024 Jun.
Article in En | MEDLINE | ID: mdl-39036132
ABSTRACT
Myxedema coma (MC) is a potentially fatal complication of hypothyroidism, with a high mortality rate. It is a clinically diagnosed condition, where the symptoms are related to decreased metabolic effects due to low active thyroid hormones. This case report highlights a severe case of MC, despite the thyroid stimulating hormone (TSH) being normal and the free thyroxine (FT4) being very mildly decreased.
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cureus Year: 2024 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cureus Year: 2024 Document type: Article Affiliation country: Country of publication: